Patil Neena M — SEC Form 4 filings
SEC reporting owner CIK 1783908. 18 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-01-19 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 7 filings — 71,692 shares, $13,055,648 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 16,602 shares @ $192.53 ($3,196,335) in Jazz Pharmaceuticals plc, filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | EVP & Chief Legal Officer | 15 | — | 17 legs · 71,692 sh · $13,055,648 | 22 |
| TELEFLEX INC (TFX) | Director | 3 | — | — | 6 |
Form 4 filings — Patil Neena M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,200 @ $240.94 | EDGAR |
| 2026-07-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 2,678 @ $237.72 | EDGAR |
| 2026-06-12 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,200 @ $231.83 | EDGAR |
| 2026-06-01 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,192 @ $236.97 | EDGAR |
| 2026-05-19 | 4 | TELEFLEX INC (TFX) | Grant/award (A): 1,090 @ $0 · Grant/award (A): 2,397 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 5,000 @ $188.69 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 20,125 @ $113.10 · Sale (S): 16,602 @ $192.53 · Option exercise (M): 875 @ $113.10 · Sale (S): 875 @ $192.07 · Option exercise (M): 27,084 @ $137.12 · Sale (S): 15,555 @ $190.28 · +14 more | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 8,852 @ $0 · Disposition to issuer (D): 3,275 @ $171.16 | EDGAR |
| 2025-05-13 | 4 | TELEFLEX INC (TFX) | Grant/award (A): 1,051 @ $0 · Grant/award (A): 2,226 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 4,088 @ $138.95 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,800 @ $144.87 · Grant/award (A): 12,518 @ $0 · Grant/award (A): 5,778 @ $0 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 5,864 @ $0 · Tax withholding (F): 1,905 @ $122.62 | EDGAR |
| 2024-11-13 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,700 @ $123.41 | EDGAR |
| 2024-05-09 | 4 | TELEFLEX INC (TFX) | Grant/award (A): 649 @ $0 · Grant/award (A): 1,349 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 5,000 @ $109.65 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 3,432 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 12,348 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 5,087 @ $0 · Tax withholding (F): 1,656 @ $119.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1783908 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →